Oncolytics Biotech
$1.05
24H
Market Cap
Volume
Supply
Price Chart
About Oncolytics Biotech - ONCY
Oncolytics Biotech Inc. is a development-stage biopharmaceutical company focused on the discovery and development of oncolytic viruses as potential cancer therapeutics. Their work primarily centers around the use of reovirus-based products to target and destroy cancer cells without harming normal cells.
What are Oncolytics Biotech's core values and mission statement?
Oncolytics Biotech Inc.'s mission is to develop and commercialize oncolytic viruses as potential therapeutics for use in a broad range of cancers. The core values include a commitment to scientific excellence, innovation, and collaboration with the goal of improving outcomes for cancer patients.
Who founded Oncolytics Biotech and when?
Oncolytics Biotech Inc. was founded in 1998 by Dr. Matt Coffey and Dr. Brad Thompson.
Who leads Oncolytics Biotech?
As of the latest available information, Dr. Matt Coffey serves as the President and CEO of Oncolytics Biotech Inc.
Where is Oncolytics Biotech located, and what is its base country?
Oncolytics Biotech Inc. is headquartered in Calgary, Alberta, Canada, and its base country is Canada.
On which exchanges is Oncolytics Biotech traded?
Oncolytics Biotech Inc. is traded on the Toronto Stock Exchange (TSX) under the symbol ONC and on the NASDAQ under the symbol ONCY.
Historical data
Oncolytics Biotech (ONCY) Price Live Data
The live price of Oncolytics Biotech (ONCY) is $1.05, with a trading volume of 50,283 in the last 24 hours. Wrapstocks updates the ONCY price in real-time. Oncolytics Biotech is up 0.96% in the last 24 hours. The company has a live market cap of $80,909,736.00 and a supply of 77,056,891 ONCY stocks.
Oncolytics Biotech (ONCY) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 16 hours and 39 minutes.
